loading
ʻO ka ʻepekema ma hope
Hoʻōla Haʻalulu Sonic
Ma ke ʻano he mea hana ʻoihana o ka ʻenehana haʻalulu sonic, ke manaʻoʻiʻo nei mākou he pono e hoʻopaʻa ʻia nā ʻike huahana kūikawā i nā hōʻike ʻepekema paʻa. Ua hōʻike kikoʻī ʻia nā kumumanaʻo kumu a me nā ʻano hana loea o ka Vibroacoustic Therapy (VAT) ma kā mākou [ʻAoʻao ʻenehana] .
No ka hoʻokō ʻana i kēia, hōʻuluʻulu kēia ʻaoʻao i 45 mau pepa noiʻi i loiloi ʻia e nā hoa i paʻi ʻia ma PubMed, PubMed Central, a me nā puke pai lapaʻau koʻikoʻi o ka honua - e uhi ana i 8 mau māhele noi lapaʻau koʻikoʻi.
45
Nā Pepa Noiʻi
8
Nā Māhele Lapaʻau
10+
Nā Puke Pai Alakaʻi
Hoʻopau ʻeha a me ka hoʻōla hou ʻana
ʻAʻole pono ka ʻeha mau loa ke kumu mua. ʻO kā mākou haʻalulu alapine haʻahaʻa i hoʻonohonoho pono ʻia - i aʻo ʻia ma ke ʻano lapaʻau ma 40 Hz - hana pololei ma kāu ʻōnaehana nerve e hōʻemi i ka ʻeha i ʻike ʻia, hōʻoluʻolu i ka ʻeha o nā ʻiʻo, a hoʻolalelale i ka hoʻōla ʻana. Inā ʻoe e hoʻokele nei i ka fibromyalgia, e hoʻōla ana mai ke ʻoki kino, a i ʻole ke noho nei me ka ʻeha hope mau, hōʻike ka ʻepekema hiki i ke kani ke hana i nā mea hiki ʻole i nā pila ke hana.
ʻO ka Vibroacoustic Therapy no ka ʻeha mau loa: He Scoping Review
Nānā ʻia he 430 mau moʻolelo; 20 mau haʻawina i hoʻokomo ʻia. ʻO ke alapine mua 40 Hz, ka lōʻihi o ka hālāwai he 20-45 min. Ua hōʻike ʻia nā haʻawina he nui i ka emi ʻana o ka ʻeha i ʻike ʻia i nā heluna kanaka me ka ʻeha mau, e hōʻoia ana i kahi ʻano hopena analgesic.
Hoʻoulu Leo Haʻahaʻa-Alapine no Fibromyalgia
Ua loaʻa i nā maʻi fibromyalgia he 19 mau kau 40 Hz ʻelua manawa i ka hebedoma no 5 mau pule. Ma hope o 10 mau kau, ua hoʻōki ʻo 25% i nā lāʻau lapaʻau analgesic āpau; ua hoʻomaikaʻi nui ʻia ka hiamoe, ke kaumaha, a me ka cervical ROM.
ʻO ka haʻalulu kino holoʻokoʻa no ka ʻeha hope haʻahaʻa mau loa: He Hoʻohou Noiʻi
RCT ma 120 mau maʻi ʻeha haʻahaʻa mau loa: WBV ʻelua manawa i ka pule no 3 mahina. Ua hoʻomaikaʻi nui ʻia ka helu ʻeha VAS, ka Oswestry Disability Index, a me ka ikaika o nā ʻiʻo o ka iwi kuamoʻo.
Meta-Analysis: WBV ma ka ʻeha ʻiʻo lohi
Meta-analysis o 9 RCTs (n=263): Hoʻemi maikaʻi ʻo WBV i ka DOMS ma hope o ka hoʻoikaika kino, hoʻokiʻekiʻe i ka paepae ʻeha-paʻakikī, a hoʻolalelale i ka hoʻōla ʻana o ka ikaika.
ʻO ka hoʻoponopono hou ʻana o Vibroacoustic ma hope o ke kūkulu hou ʻana o ACL
RCT ma 24 mau maʻi ma hope o ke kūkulu hou ʻana o ACL. Ua hōʻike ka hui Vibroacoustic i ka ROM kuli kiʻekiʻe, ka ikaika o nā ʻiʻo isokinetic, nā helu ʻeha, a me ka hoʻāla parasympathetic vs. ka hoʻoponopono hou ʻana maʻamau.
WBV no ke ʻano o ke ola, ka ʻeha a me ka luhi ma Fibromyalgia (Cochrane Review)
Loiloi ʻōnaehana o 4 RCTs (n=150): Ua hoʻomaikaʻi nui ʻo WBV i hui pū ʻia me ka hoʻoikaika kino i ke ʻano o ke ola (FIQ +16%), ʻeha (−28%), a me ka luhi (−33%) i nā poʻe maʻi fibromyalgia.
Hoʻomaʻamaʻa Paʻa + Leo Vibroacoustic no ka ʻeha ʻāʻī mau loa
RCT ma 36 mau maʻi ʻeha ʻāʻī mau loa. Ua hōʻike ka hui Vibroacoustic i nā hoʻomaikaʻi koʻikoʻi i ka hopena ʻeha poʻo HIT-6, ka helu ʻeha NRS, a me ke kani ʻiʻo; ʻaʻole i hōʻike ka hui kaohi i kahi loli koʻikoʻi.
Hana Neurology a me Motor
Hoʻoulu ka ʻōnaehana nerve i ka rhythm. Ma o ka haʻalulu o ke kino holoʻokoʻa i hoʻoponopono pono ʻia, hoʻāla kā mākou ʻenehana i nā ala proprioceptive hohonu - nā kaapuni neural like i kuleana no ke kaulike, ka hoʻonohonoho ʻana, a me ka hoʻōla ʻana i ka neʻe ʻana. Kākoʻo ʻia e nā hōʻike lapaʻau ma waena o ka hahau ʻana, ka maʻi Parkinson, ka cerebral palsy, a me ka sclerosis maha, ke wehewehe hou nei ka lāʻau hoʻōla haʻalulu i ke ʻano o ka hoʻōla hou ʻana.
WBV no ka Hana Kino, ADL, a me QoL i nā maʻi hahau: Loiloi ʻōnaehana a me ka Meta-Analysis
25 mau haʻawina, 991 mau maʻi hahau. Ua hoʻomaikaʻi nui ka hoʻomaʻamaʻa WBV i ke kaulike, ka hele ʻana, a me nā hana o ke ola o kēlā me kēia lā - ua hōʻoia ʻia he mea kōkua kūpono i ka hoʻōla hou ʻana i ka hahau.
Hoʻomaikaʻi ʻo WBV i ke kaulike a me ka pono o ka hele wāwae i nā poʻe maʻi stroke hemiplegic
RCT ma 30 mau maʻi hahau: ʻoi aku ka maikaʻi o ka WBV 2-pule 10 Hz ma mua o nā kaohi ma ka hiki ke hoʻololi kaumaha ʻaoʻao, ka manawa kū wāwae hoʻokahi, ka hoʻāʻo hele wāwae 10-m, a me ka hoʻāʻo noho-a-kū.
WBV no nā hōʻailona motor i ka maʻi o Parkinson: loiloi ʻōnaehana a me ka meta-analysis
Meta-analysis o 8 RCTs (n=255): Ua hoʻomaikaʻi nui ʻo WBV i ke kaulike (SMD=0.58) a me ka hana hele wāwae (SMD=−0.48) i ka maʻi o Parkinson - i hoʻokumu ʻia ma ke ʻano he lāʻau lapaʻau adjunct kūpono.
Nā hopena olakino a me nā hana o WBV i nā keiki a me nā ʻōpio me Cerebral Palsy
Loiloi ʻōnaehana o 8 RCTs (n=227). WBV ma 5–30 Hz, amplitude ≤9 mm, hoʻomaikaʻi ʻia ka hana neʻe, spasticity, a me ka hiki ke hele wāwae i nā keiki me CP.
WBV no ka ikaika o nā ʻiʻo a me ka neʻe ʻana o ka hana ma ka Multiple Sclerosis: Meta-Analysis
Meta-analysis o 7 RCTs (n=201): Ua hoʻomaikaʻi nui ʻo WBV i ka ikaika o ka extensor kuli (WMD=13.74) a me ka neʻe ʻana o ka hana i nā poʻe maʻi sclerosis lehulehu.
Ka Hoʻohana Lapaʻau o ka Hoʻoulu ʻana i ka Haʻalulu i ka Hoʻōla Hou ʻana o ka Cerebral Palsy
Nānā i nā holomua o WBV i ka hoʻoponopono hou ʻana o CP me ka hoʻoikaika ʻana i nā lālā haʻahaʻa, ka hoʻomaikaʻi ʻana i ke kaulike, a me ka hoʻolaha ʻana i ka hana neʻe nui; hāʻawi i ka ʻike lapaʻau.
Ola Kino a me ka Ikaika o nā ʻIʻo
ʻAʻole kūkulu ʻia nā iwi ikaika a me nā ʻiʻo paʻa e ka hopena wale nō - pane lākou i ka haʻalulu. Ua hōʻoia nā haʻawina lapaʻau e hoʻoulu ka haʻalulu o ke kino holoʻokoʻa ma 30 Hz i ka hana osteoblast, hoʻonui i ka nui o ka mineral iwi, a pale aku i ka nalowale o ka nui o nā ʻiʻo e hele mai me ka makahiki a i ʻole ka hana ʻole. Inā he mea pāʻani ʻoe e pale ana i ka pono o nā hui a i ʻole he pākeke e mālama ana i ka sarcopenia, hāʻawi ka haʻalulu i nā hopena kūkulu hiki ke ana ʻia.
Ka hopena o ka haʻalulu kino holoʻokoʻa 30 Hz ma ka Osteoporosis
Ua loaʻa i 70 mau wahine postmenopausal he 30 Hz, 0.2–0.3G vibration no 12 mau mahina. Ua piʻi nui ka BMD o ka iwi kuamoʻo lumbar a me ka ʻūhā - e hōʻoia ana i ka 30 Hz ʻo ia ke alapine kūpono no ka hoʻoulu ʻana i ka ulu ʻana o ka iwi.
Ka Hopena o ka Haʻalulu Alapine Haʻahaʻa ma ka Osteogenesis
Ua hōʻoia ka loiloi he 30 Hz ke alapine kūpono no ka ulu ʻana o ka iwi. ʻAno hana: hoʻāla i ka hōʻailona Wnt/β-catenin e hoʻolaha i ka hoʻokaʻawale ʻana o ka osteoblast a kāohi i ka hana osteoclast - waiwai koʻikoʻi no ka hana osteoporosis.
Hoʻomaʻamaʻa WBV no Sarcopenia i ka poʻe ʻelemakule
40 mau maʻi sarcopenic ʻelemakule: 8 mau pule o ka WBV ʻaoʻao-alternating (9-14 Hz) i hoʻomaikaʻi nui i ka ikaika o nā lālā haʻahaʻa, ka wikiwiki o ke hele ʻana 6-m, TUGT, a me nā hōʻailona kaulike - ke komo hou ʻana no ka sarcopenia.
Ka hopena o ka hoʻoulu ʻana o ka haʻalulu ma ka luhi o nā ʻiʻo
Hōʻike ka loiloi sEMG i ka hoʻomaʻamaʻa haʻalulu e hoʻopaneʻe i ka hoʻomaka ʻana o ka luhi o nā ʻiʻo, hoʻihoʻi i nā waiwai electrophysiological o nā ʻiʻo skeletal a me ka ikaika, a hōʻoluʻolu pono i ka luhi i hoʻokumu ʻia e ka hoʻoikaika kino.
ʻO WBV ma ka ikaika o ke kuli Flexor/Extensor i nā mea pāʻani pôpeku
Ua hoʻopau nā mea pāʻani pôpeku he 20 i 8 mau pule o ka hoʻomaʻamaʻa WBV 30 Hz. ʻOi aku ka ikaika o ka flexor/extensor kuli kiʻekiʻe a me ke ahonui ʻiʻo ma mua o ka hui hoʻomaʻamaʻa ikaika maʻamau.
Nā hopena o WBV ma ka Osteoarthritis Knee
ʻO ke kumu hoʻohālike OA kuli lāpaki: Ua hoʻomaikaʻi ʻo WBV (40 Hz, 2–4 mm, 4 pule) i ka microstructure o ka iwi subchondral, hoʻonui i ka hapa nui o ka iwi a me BMD, a hoʻemi i ka hoʻokaʻawale trabecular.
Hoʻomaha i ke kaumaha a me ke olakino noʻonoʻo
ʻŌlelo kāu ʻōnaehana nerve ma nā alapine (frequencies). Ua hōʻike ʻia ma ke ʻano lapaʻau ka hoʻoulu ʻana o ka vibroacoustic haʻahaʻa alapine (frequency) e hoʻololi i ke kino i kahi kūlana parasympathetic - ke kū'ē olaola o ke kaumaha. Hōʻoia nā ana EEG a me HRV e hōʻemi ana kahi kau hoʻokahi i ka cortisol, hoʻomālielie i ka walaʻau noʻonoʻo, a hoʻomaʻamaʻa i ka lolo i ka mālie nui. E noʻonoʻo iā ia he noʻonoʻo hiki iā ʻoe ke manaʻo.
Nā hopena hoʻoulu Vibroacoustic ma ke kaumaha Psychological, Physiological, a me Cognitive
Ua hōʻoia ʻia nā ana biometric ECG a me EEG: ua hoʻonui ka hoʻoulu ʻana o ka vibroacoustic i ka hana o ka ʻōnaehana nerve parasympathetic i nā mea komo a pau; Ua hōʻike ʻo EEG i ka hoʻonui ʻana i ka noʻonoʻo, ka hoʻemi ʻana i ka hoʻāla ʻana, a me ka hoʻonui ʻana i ka hoʻomaha.
Hoʻoulu ʻana o Vibroacoustic a me ka loli ʻana o ka helu o ka puʻuwai (Pilot RCT)
ʻO ka RCT hoʻāʻo ma nā haumāna kulanui: ua hoʻonui ka haʻalulu alapine haʻahaʻa i ka neʻe ʻana o ka HRV i ke kaulike parasympathetic nui aʻe, e hōʻemi nui ana i ke kaumaha pilikino a me ka ʻūlū ʻiʻo - nā hōʻike hoʻomaha kaumaha ma ka pae physiological.
Nā Hana Hoʻopilikia Haʻalulu no ka Hoʻemi ʻana i ke Koʻikoʻi
Ua hoʻohaʻahaʻa nui ka haʻalulu paʻi alapine haʻahaʻa i nā helu koʻikoʻi subjective a me nā pae cortisol salivary - nā hōʻike ʻepekema pae biomarker no ka pono o VAT i ka hoʻokele koʻikoʻi koke.
Hoʻoulu ʻana i ka ʻike Rhythmic no ka maʻi kaumaha nui
Ua loaʻa i nā maʻi he 20 me ke kaumaha nui he 5 mau pule o ka hoʻoulu ʻana o ka vibroacoustic gamma-frequency 30-70 Hz; 37% i hoʻokō i nā koina pane lapaʻau ma ka Montgomery–Åsberg Depression Rating Scale.
Nā hopena hoʻoulu Vibroacoustic ma ka pono o ka noʻonoʻo, ka noʻonoʻo ʻana, a me ka hoʻomaha ʻana
Ua hōʻike ka loiloi EEG i ka hoʻonui ʻana o VAT i nā biomarkers kuʻuna a me ka hoʻemi ʻana i ka hoʻāla ʻana o ka noʻonoʻo i hoʻohālikelike ʻia me ka hoʻomaha a me ka noʻonoʻo ʻana i ka noʻonoʻo - nā hōʻike neurophysiological objective.
ʻO Neurophysiology o ka Vibroacoustic-Enhanced Breath Mindfulness no ka Dissociation
Ma kahi RCT ma luna o 65 mau wahine i hōʻeha ʻia me ka dissociative PTSD, ua hana maikaʻi ʻo VBFM ma mua o ka noʻonoʻo maʻamau. Ua hoʻoikaika ia i ka interoception, ka nānā ʻana, ka pilina neural a me HRV, e hōʻike ana i ka hoʻoponopono ʻana o ka vibroacoustic therapy i nā pilikia nui i ka mālama ʻana i ka trauma.
Hoʻomaikaʻi hiamoe
ʻAʻole pilikia ka hiamoe ʻana i ka manaʻo ikaika - he pilikia ia o ka ʻōnaehana nerve. Hoʻohālike ka haʻalulu alapine haʻahaʻa i ka neʻe mālie ʻana i hoʻomālielie i nā kānaka e hiamoe no nā tausani makahiki, a i kēia manawa ua hōʻoia nā haʻawina fMRI lapaʻau a me nā haʻawina hiamoe objective e hana ana. ʻO ka lohi hiamoe pōkole, ʻoi aku ka maikaʻi o ka hiamoe, a me ka hiamoe hohonu i hoʻomaikaʻi ʻia - me ka ʻole o hoʻokahi pila.
Ka hopena o ka haʻalulu kino holoʻokoʻa 30 Hz ma ka Osteoporosis
Ua loaʻa i 70 mau wahine postmenopausal he 30 Hz, 0.2–0.3G vibration no 12 mau mahina. Ua piʻi nui ka BMD o ka iwi kuamoʻo lumbar a me ka ʻūhā - e hōʻoia ana i ka 30 Hz ʻo ia ke alapine kūpono no ka hoʻoulu ʻana i ka ulu ʻana o ka iwi.
Ka Hopena o ka Haʻalulu Alapine Haʻahaʻa ma ka Osteogenesis
Ua hōʻoia ka loiloi he 30 Hz ke alapine kūpono no ka ulu ʻana o ka iwi. ʻAno hana: hoʻāla i ka hōʻailona Wnt/β-catenin e hoʻolaha i ka hoʻokaʻawale ʻana o ka osteoblast a kāohi i ka hana osteoclast - waiwai koʻikoʻi no ka hana komo ʻana o ka osteoporosis.
Hoʻomaʻamaʻa WBV no Sarcopenia i ka poʻe ʻelemakule
40 mau maʻi sarcopenic ʻelemakule: 8 mau pule o ka WBV ʻaoʻao-alternating (9-14 Hz) i hoʻomaikaʻi nui i ka ikaika o nā lālā haʻahaʻa, ka wikiwiki o ke hele ʻana 6-m, TUGT, a me nā hōʻailona kaulike - ke komo hou ʻana no ka sarcopenia.
Ka hopena o ka hoʻoulu ʻana o ka haʻalulu ma ka luhi o nā ʻiʻo
Hōʻike ka loiloi sEMG i ka hoʻomaʻamaʻa haʻalulu e hoʻopaneʻe i ka hoʻomaka ʻana o ka luhi o nā ʻiʻo, hoʻihoʻi i nā waiwai electrophysiological o nā ʻiʻo skeletal a me ka ikaika, a hōʻoluʻolu pono i ka luhi i hoʻokumu ʻia e ka hoʻoikaika kino.
ʻO WBV ma ka ikaika o ke kuli Flexor/Extensor i nā mea pāʻani pôpeku
Ua hoʻopau nā mea pāʻani pôpeku he 20 i 8 mau pule o ka hoʻomaʻamaʻa WBV 30 Hz. ʻOi aku ka ikaika o ka flexor/extensor kuli kiʻekiʻe a me ke ahonui ʻiʻo ma mua o ka hui hoʻomaʻamaʻa ikaika maʻamau.
Cardiovascular & Metabolic Health
Your cardiovascular system responds to vibration at the cellular level. Clinical evidence shows that whole-body vibration lowers arterial stiffness, improves blood glucose regulation, and upregulates circulation-promoting growth factors like VEGF and IGF-1. For those managing diabetes, COPD, or heart disease, vibration therapy offers a safe, evidence-backed complement to conventional care — with results measurable in the bloodstream.
Effects of Horizontal WBV on the Cardiovascular System: Mechanisms and Progress
Systematic review: WBV significantly reduced pulse wave velocity (PWV), augmentation index (AIx), and blood pressure; improved arterial stiffness via NO pathway and inflammatory modulation.
Effects of WBV on Blood Glucose in Elderly Type 2 Diabetic Patients
40 elderly type 2 diabetes patients: WBV training significantly lowered fasting blood glucose, HbA1c, total cholesterol, and LDL while improving quality of life.
Can WBV Improve Functional Exercise Capacity in COPD Patients?
24 outpatient COPD patients: 8 weeks of WBV combined with high-frequency chest-wall oscillation increased 6-minute walk distance by 58 m; CAT scores, SGRQ, and lower-limb muscle strength improved significantly.
Vibroacoustic Therapy for Cardiac Function in Coronary Heart Disease
Retrospective analysis of 200 CHD patients: VAT + exercise group showed superior cardiac function indicators, less anxiety and depression vs. exercise-only group — largest-sample VAT cardiac rehabilitation study to date.
WBV Increases Circulating Stem/Progenitor Cells and Attenuates Inflammation
WBV upregulates circulating VEGF, IGF-1, and other cytokines, promotes angiogenesis, suppresses inflammatory responses, and improves muscle metabolism — cellular-mechanism evidence for cardiovascular protection.
Brain Health & Cognition
40 Hz is the frequency of a healthy, alert brain — and it's now the focus of some of the most exciting neuroscience on the planet. MIT researchers have shown that 40 Hz vibration clears amyloid plaques, reduces tau protein, and activates the brain's own glymphatic waste-removal system. From sharper daily cognition to long-term protection against Alzheimer's, the science of gamma-frequency vibration is rewriting what's possible for brain health.
Gamma Frequency Entrainment Attenuates Amyloid Load and Modifies Microglia
Landmark paper: 40 Hz sensory stimulation reduced amyloid-β levels and plaque burden in Alzheimer's mouse models while activating microglia to clear toxic proteins.
40 Hz Vibrations Reduce Alzheimer's Pathology in Mouse Models
First demonstration that 40 Hz tactile vibration reduces phosphorylated tau, prevents neuron death, and preserves synaptic connections — direct evidence for vibroacoustic device intervention in Alzheimer's disease.
GENUS Clinical Feasibility in Mild Alzheimer's Dementia
Phase I (n=43) and Phase IIA (n=15) randomized trials confirmed that 40 Hz audiovisual stimulation safely entrains cortical gamma activity; daily use for 3 months was safe and well-tolerated.
Long-Term 40 Hz Gamma Stimulation in Alzheimer's Patients (2-Year Follow-Up)
Ua loaʻa i 5 mau maʻi Alzheimer ʻoluʻolu he 1 hola/lā o ka hoʻoulu ʻana o ka leo leo 40 Hz no ~2 mau makahiki. I ka hoʻohālikelike ʻia me kahi hui waihona ʻikepili i kūlike, ua hoʻēmi ʻia ka emi ʻana o ka ʻike; ua hōʻoia ʻia ka palekana lōʻihi me ka ʻole o nā hanana maikaʻi ʻole.
40 Hz Auditory Stimulation Clears Amyloid in Primates
Aged rhesus macaques received 1 week of 40 Hz auditory stimulation. CSF amyloid-β rose ~200% (indicating active clearance from brain tissue); the effect persisted for 5 weeks after stimulation ended.
Review: Expanding Evidence That 40 Hz Gamma Stimulation Promotes Brain Health
Comprehensive decade-long review: 40 Hz stimulation via light, sound, or tactile vibration reduces Alzheimer's pathological hallmarks and shows potential for Parkinson's disease, stroke, anxiety, and epilepsy.
Beauty & Skin Health
True skin transformation starts beneath the surface. Vibroacoustic stimulation has been shown to stimulate dermal fibroblast proliferation, upregulate the COL3A1 collagen gene, and reduce skin inflammation at the molecular level. The result: firmer, more hydrated skin; improved scalp circulation; and a natural lifting effect — driven not by chemicals, but by the body's own cellular response to sound.
Mechanical Stimulation Induces Rapid Fibroblast Proliferation and Accelerates the Early Maturation of Human Skin Substitutes
Mechanical stimulation of collagen hydrogels using cyclic biaxial tension increased the fibroblast count by 75% compared to static culture, while promoting extracellular matrix protein expression and keratinocyte proliferation, thereby proving that mechanical vibration can directly activate fibroblasts to enter the cell cycle.
Vibrational Stress Affects ERK Activation and Cytoskeleton Structure in Human Keratinocytes
Mechanical vibration at 45 Hz reorganizes the keratinocyte cytoskeleton, activates the ERK1/2 signaling pathway, and upregulates HB-EGF and EGFR gene expression, leading to the study's conclusion that mechanical vibration possesses significant potential to accelerate cutaneous wound healing.
Changes in Skin Microcirculation Resulting from Vibration Therapy in Women with Cellulite
In a study where 57 women underwent 15 vibration therapy sessions, skin thermography revealed a significant rise in skin temperature across the buttocks and thighs alongside a marked reduction in cellulite grade, concluding that vibration therapy effectively enhances skin microcirculation.
The Impact of Vibration Therapy on Skin Condition in Young Women with Lipodystrophy: A Pilot Study
Following 20 vibration interventions (5 times per week, 60 minutes per session) among 10 women, cellulite completely resolved in 40% of the participants, while the remaining 60% showed substantial improvement in skin condition, accompanied by simultaneous enhancements in both skin hydration and transepidermal water loss (TEWL) indicators.
E pili ana i kā mākou lako
ʻO ka hapa nui o nā mea haʻalulu ma ka mākeke e hilinaʻi nei i ka haʻalulu mechanical i hoʻokele ʻia e ka motika. ʻO Didahealthy kekahi o nā lama wale nō e hoʻohana ana i ka ʻenehana haʻalulu sonic ʻoihana - i kūkulu ʻia no ka hāʻawi ʻana i nā alapine pololei a pili pono i ka lāʻau lapaʻau i ʻōlelo ʻia ma ka noiʻi ma luna.
3–50 Hz
Uhi i ka laulā piha i aʻo ʻia ma ke ʻano lapaʻau - mai ka 30 Hz kūpono no ka hoʻoulu ʻana o ka iwi a hiki i ka 40 Hz gamma frequency i hoʻohana ʻia ma ka noiʻi ʻana o Alzheimer.
Hoʻololi piha ʻia
Ka mana kūpono o ka amplitude a me ka wikiwiki i kēlā me kēia kau. ʻAʻole hāʻawi nā hāmeʻa ʻano motika, ʻano crank, a me ke ʻano seesaw i ka ikaika hiki ke hoʻololi ʻia - paʻa ka mea āu e loaʻa ai.
Kū pololei pololei
ʻO ka haʻalulu kū pololei maoli me ka hoʻouna pololei - e hoʻohālikelike ana i ke axis mechanical i hoʻohana ʻia i nā hoʻokolohua WBV lapaʻau. Hoʻopuka nā ʻano seesaw a me nā motika i ka lūlū ʻaoʻao, ʻaʻole ka hoʻoulu kū maoli.
ʻole
ʻAʻole hoʻopuka ka haʻalulu leo ​​i ka walaʻau mīkini. Hoʻopuka nā mea hoʻokūkū i hoʻokele ʻia e ka mīkini i ka walaʻau lohe nui; hoʻopuka nā ʻano crank a me seesaw i ka walaʻau waena - nā mea a pau e hoʻopilikia ana i nā kau hoʻōla.
Paʻa mau loa
ʻO ka ʻole o nā ʻāpana mīkini e neʻe ana, ʻaʻohe ia e ʻaʻahu a haehae. ʻO ka motika, ka crank, a me nā mea hana ʻano seesaw a pau he haʻahaʻa ka lōʻihi ma muli o ke kaumaha mau o ka mīkini ma nā ʻāpana e neʻe ana.
Kiʻekiʻe
Hoʻopuka kūlike, hiki ke hana hou ʻia i kēlā me kēia kau. ʻO ke ʻano o nā ʻano motika ka wikiwiki waena; ʻo ke ʻano o nā crank ka wikiwiki haʻahaʻa. Hāʻawi ka ʻenehana sonic i ke ʻano nalu like me ka ʻole o ka drift a i ʻole ka degradation i ka hala ʻana o ka manawa.
Nā ʻōlelo hoʻokuʻu
ʻO nā haʻawina i hōʻuluʻulu ʻia ma kēia ʻaoʻao e mālama ʻia e nā ʻoihana noiʻi kūʻokoʻa. ʻAʻole i kākoʻo kālā a komo paha ʻo Dida Healthy i kēia mau noiʻi. Ke hōʻike nei mākou i kēia mau palapala no ka ʻike ʻepekema a me nā kumu hoʻonaʻauao wale nō, ʻaʻole ma ke ʻano he mau koi lapaʻau.

ʻŌlelo Aʻo Lapaʻau: Pono nā kānaka me nā kūlana olakino kūikawā, nā wāhine hāpai, a i ʻole nā ​​mea hoʻohana me nā mea hoʻokomo lāʻau lapaʻau e kūkākūkā me kahi loea mālama ola ma mua o ka hoʻohana ʻana.
Hoʻokaʻaʻike: No nā nīnau hoʻonaʻauao a i ʻole nā ​​noi pepa, e hoʻokaʻaʻike:lijiajia1843@gmail.com
ʻO Guangzhou Sunwith Healthy Technology Co., Ltd. he hui i hoʻolako ʻia e Zhenglin Pharmaceutical, i hoʻolaʻa ʻia i ka noiʻi.
+ 86 15989989809


Ule kū Weia
Mea hoʻopili: Sofia Lee
WhatsApp:+86 159 8998 9809
leka uila:lijiajia1843@gmail.com
Hoʻohui:
West Tower o Guomei Smart City, No.33 Juxin Street, Haizhu District, Guangzhou Kina
Kuleana kope © 2024 Guangzhou Sunwith Healthy Technology Co., Ltd. - didahealthy.com | ʻaiohao
Customer service
detect